Resmed (RMD) Notes Payables (2016 - 2025)
Historic Notes Payables for Resmed (RMD) over the last 11 years, with Q4 2025 value amounting to $259.9 million.
- Resmed's Notes Payables rose 252372.3% to $259.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $259.9 million, marking a year-over-year increase of 252372.3%. This contributed to the annual value of $9.9 million for FY2025, which is 0.0% changed from last year.
- Per Resmed's latest filing, its Notes Payables stood at $259.9 million for Q4 2025, which was up 252372.3% from $259.9 million recorded in Q3 2025.
- Resmed's Notes Payables' 5-year high stood at $259.9 million during Q4 2025, with a 5-year trough of $9.9 million in Q3 2024.
- Its 5-year average for Notes Payables is $35.4 million, with a median of $9.9 million in 2022.
- Per our database at Business Quant, Resmed's Notes Payables plummeted by 1750.0% in 2022 and then surged by 252630.36% in 2025.
- Resmed's Notes Payables (Quarter) stood at $12.0 million in 2021, then fell by 17.5% to $9.9 million in 2022, then decreased by 0.02% to $9.9 million in 2023, then rose by 0.08% to $9.9 million in 2024, then soared by 2523.72% to $259.9 million in 2025.
- Its Notes Payables was $259.9 million in Q4 2025, compared to $259.9 million in Q3 2025 and $9.9 million in Q2 2025.